AstraZeneca Acquires Modella AI
January 15, 2026
AstraZeneca has acquired Modella AI, a Boston-based biomedical AI company, to integrate its multimodal foundation models and agentic AI platform into AstraZeneca's global oncology R&D organization. The deal expands an existing multi-year collaboration to accelerate clinical development, improve biomarker discovery, and drive data-driven decision-making across AstraZeneca's oncology pipeline; financial terms were not disclosed.
- Buyers
- AstraZeneca
- Targets
- Modella AI
- Industry
- AI & Machine Learning
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.